Zhejiang Hisun Pharmaceutical Co., Ltd. Class ASSE: 600267

Report for Q1 2026

Apr 28, 2026 · Issued by Zhejiang Hisun Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Report for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment